Retinitis Pigmentosa (RP)
23
7
9
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (23)
Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)
Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Intravitreal Adalimumab in Inherited and Degenerative Retinal Diseases
Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases
Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital
UGX202 Injection in Patients With Advanced Retinitis Pigmentosa
Wide Field OCTA in Ocular Diseases
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa
Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies
Functional Assessments in Vision Impairment
Retinal Investigation Using Optos OCT Device
Retrospective Natural History Study of Retinitis Pigmentosa
Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)